Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-1|1|43|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-2|1|68|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-3|1|150|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-4|1|186|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-5|1|203|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-6|1|377|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-7|1|391|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-8|1|430|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-9|1|437|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-10|1|444|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions 
|9-8-1-11|1|491|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-12|1|523|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-13|1|533|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-14|1|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-15|1|586|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-16|1|593|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-17|1|599|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-18|1|608|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-19|1|618|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-20|1|642|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-21|1|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-22|1|684|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-23|1|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-24|1|690|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-25|1|695|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-26|1|699|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-27|1|709|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-28|1|747|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-29|1|249|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-30|1|276|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-31|1|276|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-32|1|305|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-33|1|489|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-34|1|493|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-35|1|539|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-36|1|577|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-37|1|586|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-38|1|589|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-39|1|590|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-40|1|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-41|1|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-42|1|626|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-43|1|630|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-44|1|632|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-45|1|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-46|1|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-47|1|685|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-48|1|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-49|1|689|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-50|1|699|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-51|1|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-52|1|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-53|1|705|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-54|1|710|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-55|1|713|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-56|1|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-57|1|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-58|1|719|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-59|1|721|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-60|1|724|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-61|1|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-62|1|730|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-63|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-64|1|737|Other deterministic changes|Lower respiratory system|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-65|1|743|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-66|1|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-67|1|797|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-1|X-Cl-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|68 (68 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-1-68|1|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-1|2|136|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-2|2|179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-3|2|538|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-4|2|572|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-5|2|587|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-6|2|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-7|2|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-8|2|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-9|2|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-10|2|637|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-11|2|659|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-12|2|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-13|2|696|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-14|2|698|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-15|2|705|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-16|2|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-17|2|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-18|2|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-19|2|710|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-20|2|712|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-21|2|714|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-22|2|714|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-23|2|715|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-24|2|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-25|2|732|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-26|2|735|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-27|2|760|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-28|2|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-29|2|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-30|2|766|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-31|2|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-32|2|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-33|2|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-34|2|789|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-35|2|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-36|2|802|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-37|2|804|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-38|2|804|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-39|2|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-40|2|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-41|2|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-42|2|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-43|2|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-44|2|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-45|2|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-46|2|830|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-47|2|832|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-48|2|834|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-49|2|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-50|2|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-51|2|843|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-52|2|851|Other deterministic changes|Lower respiratory system|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-53|2|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-54|2|903|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-55|2|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-56|2|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-2|X-Cl-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-2-57|2|909|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-1|3|279|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-2|3|335|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-3|3|395|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-4|3|399|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-5|3|404|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-6|3|428|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-7|3|463|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-8|3|485|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-9|3|503|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-10|3|510|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-11|3|545|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-12|3|550|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-13|3|576|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-14|3|582|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-15|3|583|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-16|3|586|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-17|3|595|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-18|3|598|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-19|3|604|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-20|3|622|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-21|3|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-22|3|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-23|3|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-24|3|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-25|3|653|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-26|3|671|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-27|3|673|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-28|3|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-29|3|696|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-30|3|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-31|3|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-32|3|710|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-33|3|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-34|3|719|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-35|3|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-36|3|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-37|3|730|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-38|3|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-39|3|740|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-40|3|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-41|3|780|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-42|3|788|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-43|3|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-44|3|795|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-45|3|797|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-46|3|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-47|3|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-48|3|807|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-49|3|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-50|3|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-51|3|816|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-52|3|818|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-53|3|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-54|3|825|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-55|3|830|Other deterministic changes|Lower respiratory system|n/a|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-56|3|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-3|X-Cl-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-3-57|3|923|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-1|4|333|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-2|4|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-3|4|440|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-4|4|441|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-5|4|458|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-6|4|501|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-7|4|516|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-8|4|549|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-9|4|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-10|4|574|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-11|4|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-12|4|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-13|4|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-14|4|631|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-15|4|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-16|4|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-17|4|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-18|4|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-19|4|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-20|4|709|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-21|4|712|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-22|4|713|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-23|4|724|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-24|4|725|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-25|4|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-26|4|729|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-27|4|736|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-28|4|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-29|4|742|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-30|4|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-31|4|754|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-32|4|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-33|4|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-34|4|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-35|4|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-36|4|773|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-37|4|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-38|4|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-39|4|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-40|4|787|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-41|4|793|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-42|4|796|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-43|4|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-44|4|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-45|4|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-46|4|799|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-47|4|809|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-48|4|809|Other deterministic changes|Lower respiratory system|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-49|4|814|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-50|4|820|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-51|4|826|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-52|4|832|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-53|4|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-4|X-Cl-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|54 (54 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-4-54|4|851|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-1|5|22|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-2|5|52|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-3|5|169|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-4|5|198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-5|5|284|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-6|5|365|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-7|5|412|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-8|5|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-9|5|478|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-10|5|508|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-11|5|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-12|5|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-13|5|565|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-14|5|572|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-15|5|578|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-16|5|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-17|5|588|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-18|5|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-19|5|600|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-20|5|604|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-21|5|656|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-22|5|660|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-23|5|663|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-24|5|668|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-25|5|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-26|5|684|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-27|5|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-28|5|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-29|5|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-30|5|695|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-31|5|698|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-32|5|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-33|5|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-34|5|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-35|5|725|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-36|5|727|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-37|5|728|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-38|5|734|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-39|5|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-40|5|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-41|5|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-42|5|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-43|5|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-44|5|757|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-45|5|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-46|5|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-47|5|777|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-48|5|798|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-49|5|806|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-50|5|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-51|5|817|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-52|5|822|Other deterministic changes|Lower respiratory system|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-53|5|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-54|5|830|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-55|5|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-56|5|856|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-57|5|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-5|X-Cl-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-5-58|5|891|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-1|6|145|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-2|6|187|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-3|6|204|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-4|6|213|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-5|6|227|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-6|6|234|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-7|6|245|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-8|6|451|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-9|6|460|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-10|6|477|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-11|6|558|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-12|6|574|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-13|6|581|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-14|6|582|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-15|6|582|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-16|6|582|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-17|6|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-18|6|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-19|6|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-20|6|607|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-21|6|625|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-22|6|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-23|6|638|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-24|6|651|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-25|6|656|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-26|6|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-27|6|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-28|6|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-29|6|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-30|6|695|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-31|6|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-32|6|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-33|6|704|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-34|6|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-35|6|727|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-36|6|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-37|6|733|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-38|6|735|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-39|6|736|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-40|6|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-41|6|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-42|6|749|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-43|6|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-44|6|752|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-45|6|755|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-46|6|772|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-47|6|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-48|6|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-49|6|781|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-50|6|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-51|6|784|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-52|6|786|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-53|6|798|Other deterministic changes|Lower respiratory system|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-54|6|809|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-55|6|819|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-56|6|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-6|X-Cl-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-6-57|6|846|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-1|7|81|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-2|7|126|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-3|7|315|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-4|7|397|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-5|7|423|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-6|7|445|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-7|7|500|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-8|7|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-9|7|538|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-10|7|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-11|7|602|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-12|7|615|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-13|7|648|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-14|7|658|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-15|7|668|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-16|7|682|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-17|7|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-18|7|686|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-19|7|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-20|7|711|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-21|7|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-22|7|717|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-23|7|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-24|7|741|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-25|7|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-26|7|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-27|7|750|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-28|7|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-29|7|757|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-30|7|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-31|7|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-32|7|758|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-33|7|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-34|7|759|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-35|7|768|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-36|7|768|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-37|7|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-38|7|774|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-39|7|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-40|7|777|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-41|7|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-42|7|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-43|7|780|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-44|7|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-45|7|795|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-46|7|796|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-47|7|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-48|7|802|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-49|7|806|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-50|7|813|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-51|7|816|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-52|7|819|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-53|7|825|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-54|7|826|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-55|7|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-56|7|838|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-57|7|840|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-58|7|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-59|7|866|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-7|X+Clp-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-60|7|976|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-1|7|81|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-2|7|126|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-3|7|315|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-4|7|397|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-5|7|423|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-6|7|445|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-7|7|500|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-8|7|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-9|7|538|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-10|7|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-11|7|602|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-12|7|615|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-13|7|648|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-14|7|658|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-15|7|668|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-16|7|682|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-17|7|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-18|7|686|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-19|7|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-20|7|711|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-21|7|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-22|7|717|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-23|7|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-24|7|741|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-25|7|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-26|7|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-27|7|750|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-28|7|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-29|7|757|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-30|7|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-31|7|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-32|7|758|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-33|7|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-34|7|759|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-35|7|768|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-36|7|768|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-37|7|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-38|7|774|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-39|7|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-40|7|777|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-41|7|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-42|7|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-43|7|780|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-44|7|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-45|7|795|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-46|7|796|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-47|7|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-48|7|802|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-49|7|806|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-50|7|813|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-51|7|816|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-52|7|819|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-53|7|825|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-54|7|826|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-55|7|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-56|7|838|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-57|7|840|Other deterministic changes|Lower respiratory system|n/a|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-58|7|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-59|7|866|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-7|X+Clp-Gy 0.5,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|60 (60 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-7-60|7|976|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-1|8|195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-2|8|218|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-3|8|269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-4|8|337|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-5|8|440|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-6|8|501|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-7|8|514|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-8|8|539|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-9|8|548|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-10|8|561|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-11|8|575|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-12|8|624|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-13|8|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-14|8|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-15|8|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-16|8|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-17|8|671|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-18|8|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-19|8|688|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-20|8|688|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-21|8|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-22|8|706|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-23|8|709|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-24|8|712|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-25|8|712|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-26|8|718|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-27|8|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-28|8|725|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-29|8|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-30|8|736|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-31|8|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-32|8|750|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-33|8|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-34|8|757|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-35|8|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-36|8|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-37|8|767|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-38|8|781|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-39|8|783|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-40|8|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-41|8|789|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-42|8|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-43|8|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-44|8|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-45|8|806|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-46|8|806|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-47|8|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-48|8|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-49|8|822|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-50|8|829|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-51|8|830|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-52|8|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-53|8|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-54|8|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-55|8|887|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-56|8|922|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-1|8|195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-2|8|218|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-3|8|269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-4|8|337|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-5|8|440|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-6|8|501|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-7|8|514|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-8|8|539|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-9|8|548|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-10|8|561|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-11|8|575|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-12|8|624|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-13|8|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-14|8|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-15|8|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-16|8|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-17|8|671|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-18|8|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-19|8|688|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-20|8|688|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-21|8|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-22|8|706|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-23|8|709|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-24|8|712|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-25|8|712|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-26|8|718|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-27|8|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-28|8|725|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-29|8|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-30|8|736|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-31|8|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-32|8|750|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-33|8|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-34|8|757|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-35|8|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-36|8|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-37|8|767|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-38|8|781|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-39|8|783|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-40|8|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-41|8|789|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-42|8|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-43|8|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-44|8|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-45|8|806|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-46|8|806|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-47|8|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-48|8|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-49|8|822|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-50|8|829|Other deterministic changes|Lower respiratory system|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-51|8|830|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-52|8|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-53|8|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-54|8|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-55|8|887|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-8|X+Clp-Gy 1,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-8-56|8|922|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-1|9|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-2|9|276|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-3|9|440|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-4|9|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-5|9|492|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-6|9|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-7|9|560|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-8|9|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-9|9|572|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-10|9|577|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-11|9|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-12|9|626|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-13|9|640|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-14|9|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-15|9|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-16|9|668|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-17|9|687|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-18|9|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-19|9|689|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-20|9|694|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-21|9|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-22|9|702|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-23|9|704|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-24|9|706|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-25|9|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-26|9|722|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-27|9|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-28|9|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-29|9|726|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-30|9|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-31|9|744|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-32|9|747|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-33|9|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-34|9|760|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-35|9|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-36|9|764|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-37|9|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-38|9|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-39|9|772|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-40|9|775|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-41|9|776|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-42|9|787|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-43|9|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-44|9|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-45|9|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-46|9|800|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-47|9|800|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-48|9|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-49|9|812|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-50|9|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-51|9|829|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-52|9|859|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-53|9|874|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-54|9|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-55|9|879|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-56|9|963|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-1|9|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-2|9|276|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-3|9|440|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-4|9|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-5|9|492|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-6|9|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-7|9|560|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-8|9|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-9|9|572|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-10|9|577|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-11|9|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-12|9|626|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-13|9|640|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-14|9|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-15|9|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-16|9|668|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-17|9|687|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-18|9|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-19|9|689|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-20|9|694|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-21|9|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-22|9|702|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-23|9|704|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-24|9|706|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-25|9|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-26|9|722|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-27|9|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-28|9|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-29|9|726|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-30|9|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-31|9|744|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-32|9|747|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-33|9|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-34|9|760|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-35|9|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-36|9|764|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-37|9|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-38|9|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-39|9|772|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-40|9|775|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-41|9|776|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-42|9|787|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-43|9|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-44|9|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-45|9|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-46|9|800|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-47|9|800|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-48|9|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-49|9|812|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-50|9|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-51|9|829|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-52|9|859|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-53|9|874|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-54|9|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-55|9|879|Other deterministic changes|Lower respiratory system|n/a|
9-8-9|X+Clp-Gy 2,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-9-56|9|963|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-1|10|72|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-2|10|246|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-3|10|261|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-4|10|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-5|10|479|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-6|10|517|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-7|10|518|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-8|10|529|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-9|10|552|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-10|10|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-11|10|565|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-12|10|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-13|10|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-14|10|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-15|10|619|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-16|10|622|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-17|10|627|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-18|10|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-19|10|636|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-20|10|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-21|10|668|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-22|10|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-23|10|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-24|10|682|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-25|10|683|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-26|10|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-27|10|693|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-28|10|696|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-29|10|698|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-30|10|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-31|10|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-32|10|723|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-33|10|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-34|10|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-35|10|730|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-36|10|731|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-37|10|738|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-38|10|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-39|10|741|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-40|10|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-41|10|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-42|10|769|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-43|10|770|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-44|10|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-45|10|777|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-46|10|799|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-47|10|799|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-48|10|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-49|10|824|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-50|10|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-51|10|829|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-52|10|833|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-53|10|849|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-54|10|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-55|10|868|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-56|10|894|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-57|10|918|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-1|10|72|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-2|10|246|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-3|10|261|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-4|10|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-5|10|479|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-6|10|517|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-7|10|518|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-8|10|529|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-9|10|552|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-10|10|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-11|10|565|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-12|10|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-13|10|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-14|10|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-15|10|619|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-16|10|622|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-17|10|627|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-18|10|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-19|10|636|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-20|10|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-21|10|668|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-22|10|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-23|10|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-24|10|682|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-25|10|683|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-26|10|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-27|10|693|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-28|10|696|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-29|10|698|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-30|10|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-31|10|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-32|10|723|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-33|10|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-34|10|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-35|10|730|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-36|10|731|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-37|10|738|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-38|10|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-39|10|741|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-40|10|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-41|10|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-42|10|769|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-43|10|770|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-44|10|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-45|10|777|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-46|10|799|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-47|10|799|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-48|10|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-49|10|824|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-50|10|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-51|10|829|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-52|10|833|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-53|10|849|Other deterministic changes|Lower respiratory system|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-54|10|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-55|10|868|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-56|10|894|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-10|X+Clp-Gy 4,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|57 (57 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-10-57|10|918|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-1|11|95|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-2|11|138|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-3|11|285|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-4|11|317|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-5|11|424|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-6|11|438|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-7|11|527|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-8|11|565|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-9|11|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-10|11|580|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-11|11|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-12|11|615|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-13|11|622|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-14|11|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-15|11|628|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-16|11|635|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-17|11|638|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-18|11|647|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-19|11|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-20|11|654|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-21|11|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-22|11|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-23|11|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-24|11|662|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-25|11|665|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-26|11|686|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-27|11|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-28|11|688|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-29|11|692|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-30|11|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-31|11|705|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-32|11|711|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-33|11|717|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-34|11|717|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-35|11|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-36|11|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-37|11|727|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-38|11|740|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-39|11|740|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-40|11|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-41|11|748|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-42|11|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-43|11|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-44|11|763|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-45|11|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-46|11|780|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-47|11|781|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-48|11|786|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-49|11|792|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-50|11|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-51|11|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-52|11|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-53|11|811|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-54|11|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-55|11|817|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-56|11|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-1|11|95|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-2|11|138|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-3|11|285|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-4|11|317|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-5|11|424|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-6|11|438|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-7|11|527|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-8|11|565|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-9|11|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-10|11|580|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-11|11|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-12|11|615|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-13|11|622|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-14|11|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-15|11|628|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-16|11|635|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-17|11|638|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-18|11|647|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-19|11|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-20|11|654|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-21|11|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-22|11|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-23|11|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-24|11|662|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-25|11|665|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-26|11|686|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-27|11|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-28|11|688|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-29|11|692|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-30|11|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-31|11|705|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-32|11|711|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-33|11|717|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-34|11|717|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-35|11|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-36|11|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-37|11|727|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-38|11|740|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-39|11|740|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-40|11|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-41|11|748|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-42|11|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-43|11|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-44|11|763|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-45|11|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-46|11|780|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-47|11|781|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-48|11|786|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-49|11|792|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-50|11|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-51|11|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-52|11|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-53|11|811|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-54|11|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-55|11|817|Other deterministic changes|Lower respiratory system|n/a|
9-8-11|X+Clp-Gy 6,n/a|2| 81|carbon tetrachloride|40|microliters|Gavage| gavage 69h prior expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-11-56|11|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-1|12|116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-2|12|301|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-3|12|430|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-4|12|543|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-5|12|558|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-6|12|571|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-7|12|586|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-8|12|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-9|12|621|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-10|12|625|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-11|12|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-12|12|647|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-13|12|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-14|12|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-15|12|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-16|12|678|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-17|12|678|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-18|12|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-19|12|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-20|12|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-21|12|703|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-22|12|712|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-23|12|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-24|12|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-25|12|724|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-26|12|726|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-27|12|744|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-28|12|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-29|12|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-30|12|766|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-31|12|767|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-32|12|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-33|12|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-34|12|782|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-35|12|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-36|12|786|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-37|12|794|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-38|12|795|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-39|12|795|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-40|12|797|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-41|12|797|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-42|12|802|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-43|12|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-44|12|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-45|12|805|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-46|12|813|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-47|12|813|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-48|12|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-49|12|819|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-50|12|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-51|12|822|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-52|12|830|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-53|12|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-54|12|834|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-55|12|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|1| 84|X-rays local|0.5|grays|External exposure local| single expos.upper abdomen|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-56|12|875|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-1|12|116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-2|12|301|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-3|12|430|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-4|12|543|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-5|12|558|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-6|12|571|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-7|12|586|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-8|12|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-9|12|621|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-10|12|625|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-11|12|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-12|12|647|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-13|12|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-14|12|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-15|12|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-16|12|678|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-17|12|678|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-18|12|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-19|12|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-20|12|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-21|12|703|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-22|12|712|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-23|12|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-24|12|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-25|12|724|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-26|12|726|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-27|12|744|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-28|12|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-29|12|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-30|12|766|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-31|12|767|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-32|12|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-33|12|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-34|12|782|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-35|12|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-36|12|786|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-37|12|794|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-38|12|795|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-39|12|795|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-40|12|797|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-41|12|797|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-42|12|802|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-43|12|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-44|12|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-45|12|805|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-46|12|813|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-47|12|813|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-48|12|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-49|12|819|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-50|12|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-51|12|822|Other deterministic changes|Lower respiratory system|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-52|12|830|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-53|12|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-54|12|834|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-55|12|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-12|X+Cla-Gy 0.5,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|56 (56 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-12-56|12|875|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-1|13|0|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-2|13|31|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-3|13|36|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-4|13|64|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-5|13|110|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-6|13|154|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-7|13|361|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-8|13|390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-9|13|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-10|13|527|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-11|13|530|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-12|13|532|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-13|13|552|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-14|13|554|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-15|13|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-16|13|571|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-17|13|580|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-18|13|606|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-19|13|608|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-20|13|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-21|13|637|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-22|13|643|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-23|13|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-24|13|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-25|13|693|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-26|13|700|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-27|13|706|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-28|13|719|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-29|13|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-30|13|731|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-31|13|731|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-32|13|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-33|13|740|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-34|13|743|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-35|13|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-36|13|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-37|13|772|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-38|13|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-39|13|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-40|13|779|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-41|13|783|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-42|13|784|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-43|13|785|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-44|13|788|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-45|13|794|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-46|13|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-47|13|804|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-48|13|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-49|13|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-50|13|810|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-51|13|817|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-52|13|824|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-53|13|829|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-54|13|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-55|13|836|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-56|13|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-57|13|850|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|1| 84|X-rays local|1|grays|External exposure local| single expos.upper abdomen|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-58|13|870|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-1|13|0|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-2|13|31|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-3|13|36|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-4|13|64|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-5|13|110|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-6|13|154|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-7|13|361|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-8|13|390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-9|13|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-10|13|527|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-11|13|530|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-12|13|532|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-13|13|552|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-14|13|554|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-15|13|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-16|13|571|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-17|13|580|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-18|13|606|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-19|13|608|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-20|13|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-21|13|637|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-22|13|643|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-23|13|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-24|13|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-25|13|693|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-26|13|700|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-27|13|706|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-28|13|719|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-29|13|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-30|13|731|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-31|13|731|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-32|13|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-33|13|740|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-34|13|743|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-35|13|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-36|13|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-37|13|772|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-38|13|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-39|13|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-40|13|779|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-41|13|783|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-42|13|784|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-43|13|785|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-44|13|788|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-45|13|794|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-46|13|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-47|13|804|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-48|13|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-49|13|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-50|13|810|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-51|13|817|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-52|13|824|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-53|13|829|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-54|13|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-55|13|836|Other deterministic changes|Lower respiratory system|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-56|13|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-57|13|850|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-13|X+Cla-Gy 1,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|58 (58 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-13-58|13|870|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-1|14|190|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-2|14|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-3|14|298|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-4|14|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-5|14|304|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-6|14|313|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-7|14|332|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-8|14|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-9|14|377|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-10|14|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-11|14|447|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-12|14|456|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-13|14|490|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-14|14|516|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-15|14|548|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-16|14|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-17|14|556|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-18|14|557|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-19|14|559|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-20|14|562|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-21|14|569|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-22|14|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-23|14|586|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-24|14|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-25|14|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-26|14|607|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-27|14|611|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-28|14|612|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-29|14|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-30|14|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-31|14|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-32|14|634|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-33|14|635|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-34|14|636|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-35|14|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-36|14|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-37|14|667|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-38|14|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-39|14|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-40|14|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-41|14|683|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-42|14|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-43|14|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-44|14|691|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-45|14|694|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-46|14|701|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-47|14|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-48|14|704|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-49|14|707|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-50|14|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-51|14|710|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-52|14|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-53|14|711|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-54|14|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-55|14|717|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-56|14|720|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-57|14|723|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-58|14|723|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-59|14|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-60|14|727|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-61|14|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-62|14|731|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-63|14|733|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-64|14|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-65|14|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-66|14|748|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-67|14|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-68|14|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-69|14|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-70|14|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-71|14|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-72|14|766|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-73|14|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-74|14|768|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-75|14|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-76|14|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-77|14|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-78|14|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-79|14|779|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-80|14|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-81|14|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-82|14|783|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-83|14|789|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-84|14|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-85|14|791|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-86|14|792|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-87|14|792|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-88|14|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-89|14|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-90|14|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-91|14|801|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-92|14|803|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-93|14|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-94|14|806|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-95|14|806|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-96|14|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-97|14|809|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-98|14|811|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-99|14|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-100|14|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-101|14|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-102|14|825|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-103|14|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-104|14|837|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-105|14|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-106|14|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-107|14|859|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-108|14|868|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-109|14|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-110|14|902|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-111|14|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-112|14|933|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|1| 84|X-rays local|2|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-113|14|935|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-1|14|190|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-2|14|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-3|14|298|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-4|14|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-5|14|304|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-6|14|313|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-7|14|332|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-8|14|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-9|14|377|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-10|14|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-11|14|447|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-12|14|456|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-13|14|490|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-14|14|516|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-15|14|548|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-16|14|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-17|14|556|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-18|14|557|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-19|14|559|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-20|14|562|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-21|14|569|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-22|14|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-23|14|586|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-24|14|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-25|14|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-26|14|607|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-27|14|611|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-28|14|612|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-29|14|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-30|14|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-31|14|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-32|14|634|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-33|14|635|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-34|14|636|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-35|14|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-36|14|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-37|14|667|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-38|14|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-39|14|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-40|14|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-41|14|683|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-42|14|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-43|14|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-44|14|691|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-45|14|694|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-46|14|701|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-47|14|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-48|14|704|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-49|14|707|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-50|14|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-51|14|710|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-52|14|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-53|14|711|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-54|14|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-55|14|717|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-56|14|720|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-57|14|723|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-58|14|723|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-59|14|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-60|14|727|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-61|14|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-62|14|731|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-63|14|733|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-64|14|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-65|14|746|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-66|14|748|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-67|14|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-68|14|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-69|14|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-70|14|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-71|14|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-72|14|766|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-73|14|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-74|14|768|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-75|14|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-76|14|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-77|14|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-78|14|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-79|14|779|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-80|14|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-81|14|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-82|14|783|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-83|14|789|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-84|14|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-85|14|791|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-86|14|792|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-87|14|792|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-88|14|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-89|14|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-90|14|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-91|14|801|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-92|14|803|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-93|14|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-94|14|806|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-95|14|806|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-96|14|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-97|14|809|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-98|14|811|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-99|14|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-100|14|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-101|14|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-102|14|825|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-103|14|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-104|14|837|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-105|14|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-106|14|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-107|14|859|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-108|14|868|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-109|14|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-110|14|902|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-111|14|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-112|14|933|Other deterministic changes|Lower respiratory system|n/a|
9-8-14|X+Cla-Gy 2,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-14-113|14|935|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-1|15|88|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-2|15|118|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-3|15|178|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-4|15|249|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-5|15|315|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-6|15|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-7|15|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-8|15|418|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-9|15|442|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-10|15|447|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-11|15|449|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-12|15|458|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-13|15|459|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-14|15|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-15|15|494|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-16|15|497|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-17|15|498|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-18|15|504|Neoplasia systemic|Haematolymphatic system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-19|15|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-20|15|535|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-21|15|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-22|15|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-23|15|581|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-24|15|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-25|15|593|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-26|15|595|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-27|15|599|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-28|15|606|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-29|15|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-30|15|619|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-31|15|622|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-32|15|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-33|15|632|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-34|15|638|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-35|15|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-36|15|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-37|15|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-38|15|655|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-39|15|657|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-40|15|666|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-41|15|673|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-42|15|681|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-43|15|682|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-44|15|693|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-45|15|697|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-46|15|698|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-47|15|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-48|15|703|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-49|15|703|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-50|15|704|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-51|15|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-52|15|708|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-53|15|708|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-54|15|720|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-55|15|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-56|15|721|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-57|15|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-58|15|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-59|15|725|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-60|15|727|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-61|15|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-62|15|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-63|15|731|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-64|15|736|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-65|15|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-66|15|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-67|15|744|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-68|15|747|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-69|15|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-70|15|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-71|15|752|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-72|15|753|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-73|15|755|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-74|15|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-75|15|760|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-76|15|763|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-77|15|764|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-78|15|770|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-79|15|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-80|15|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-81|15|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-82|15|790|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-83|15|792|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-84|15|793|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-85|15|794|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-86|15|798|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-87|15|798|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-88|15|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-89|15|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-90|15|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-91|15|814|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-92|15|815|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-93|15|815|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-94|15|818|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-95|15|819|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-96|15|820|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-97|15|820|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-98|15|821|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-99|15|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-100|15|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-101|15|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-102|15|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-103|15|841|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-104|15|848|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-105|15|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-106|15|853|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-107|15|855|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-108|15|863|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-109|15|889|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-110|15|893|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-111|15|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-112|15|904|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|1| 84|X-rays local|4|grays|External exposure local| single expos.upper abdomen|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-113|15|941|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-1|15|88|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-2|15|118|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-3|15|178|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-4|15|249|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-5|15|315|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-6|15|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-7|15|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-8|15|418|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-9|15|442|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-10|15|447|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-11|15|449|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-12|15|458|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-13|15|459|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-14|15|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-15|15|494|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-16|15|497|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-17|15|498|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-18|15|504|Neoplasia systemic|Haematolymphatic system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-19|15|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-20|15|535|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-21|15|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-22|15|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-23|15|581|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-24|15|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-25|15|593|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-26|15|595|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-27|15|599|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-28|15|606|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-29|15|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-30|15|619|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-31|15|622|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-32|15|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-33|15|632|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-34|15|638|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-35|15|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-36|15|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-37|15|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-38|15|655|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-39|15|657|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-40|15|666|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-41|15|673|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-42|15|681|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-43|15|682|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-44|15|693|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-45|15|697|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-46|15|698|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-47|15|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-48|15|703|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-49|15|703|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-50|15|704|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-51|15|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-52|15|708|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-53|15|708|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-54|15|720|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-55|15|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-56|15|721|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-57|15|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-58|15|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-59|15|725|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-60|15|727|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-61|15|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-62|15|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-63|15|731|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-64|15|736|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-65|15|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-66|15|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-67|15|744|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-68|15|747|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-69|15|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-70|15|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-71|15|752|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-72|15|753|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-73|15|755|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-74|15|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-75|15|760|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-76|15|763|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-77|15|764|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-78|15|770|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-79|15|770|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-80|15|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-81|15|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-82|15|790|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-83|15|792|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-84|15|793|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-85|15|794|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-86|15|798|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-87|15|798|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-88|15|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-89|15|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-90|15|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-91|15|814|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-92|15|815|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-93|15|815|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-94|15|818|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-95|15|819|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-96|15|820|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-97|15|820|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-98|15|821|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-99|15|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-100|15|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-101|15|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-102|15|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-103|15|841|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-104|15|848|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-105|15|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-106|15|853|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-107|15|855|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-108|15|863|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-109|15|889|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-110|15|893|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-111|15|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-112|15|904|Other deterministic changes|Lower respiratory system|n/a|
9-8-15|X+Cla-Gy 4,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|113 (113 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-15-113|15|941|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-1|16|131|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-2|16|138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-3|16|190|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-4|16|215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-5|16|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-6|16|294|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-7|16|304|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-8|16|392|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-9|16|419|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-10|16|433|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-11|16|486|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-12|16|495|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-13|16|500|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-14|16|512|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-15|16|518|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-16|16|546|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-17|16|553|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-18|16|558|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-19|16|595|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-20|16|596|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-21|16|596|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-22|16|603|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-23|16|611|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-24|16|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-25|16|627|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-26|16|634|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-27|16|636|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-28|16|637|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-29|16|640|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-30|16|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-31|16|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-32|16|650|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-33|16|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-34|16|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-35|16|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-36|16|666|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-37|16|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-38|16|673|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-39|16|683|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-40|16|684|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-41|16|685|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-42|16|685|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-43|16|691|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-44|16|714|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-45|16|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-46|16|722|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-47|16|726|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-48|16|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-49|16|732|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-50|16|734|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-51|16|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-52|16|736|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-53|16|748|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-54|16|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-55|16|753|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-56|16|755|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-57|16|766|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-58|16|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|1| 84|X-rays local|6|grays|External exposure local| single expos.upper abdomen|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-59|16|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-1|16|131|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-2|16|138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-3|16|190|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-4|16|215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-5|16|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-6|16|294|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-7|16|304|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-8|16|392|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-9|16|419|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-10|16|433|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-11|16|486|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-12|16|495|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-13|16|500|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-14|16|512|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-15|16|518|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-16|16|546|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-17|16|553|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-18|16|558|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-19|16|595|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-20|16|596|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-21|16|596|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-22|16|603|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-23|16|611|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-24|16|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-25|16|627|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-26|16|634|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-27|16|636|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-28|16|637|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-29|16|640|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-30|16|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-31|16|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-32|16|650|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-33|16|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-34|16|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-35|16|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-36|16|666|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-37|16|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-38|16|673|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-39|16|683|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-40|16|684|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-41|16|685|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-42|16|685|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-43|16|691|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-44|16|714|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-45|16|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-46|16|722|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-47|16|726|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-48|16|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-49|16|732|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-50|16|734|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-51|16|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-52|16|736|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-53|16|748|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-54|16|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-55|16|753|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-56|16|755|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-57|16|766|Other deterministic changes|Lower respiratory system|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-58|16|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-8-16|X+Cla-Gy 6,n/a|2| 175|carbon tetrachloride|40|microliters|Gavage| gavage 3 m after expos.|59 (59 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Young Adult|Lifespan study, number and size of liver lesions|9-8-16-59|16|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
		
